<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0411246143
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2019
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        B COR 5 MG FILM COATED TABLET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        BISOPROLOL FUMARATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        11.9
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Jordan Sweden Medical and Sterilization Co." />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Jordan Sweden Medical and Sterilization Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 679]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            AL-DAWAA MEDICAL SERVICES CO. LTD
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jordan Sweden Medical and Sterilization Co.
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C07AB07
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance in B-COR is Bisoprolol.</p><p>Bisoprolol belongs to a group of medicines called beta-blockers. These medicines work by affecting the body`s response to some nerve impulses, especially in the heart. As a result, Bisoprolol slows down the heart rate and makes the heart more efficient at pumping blood around the body.</p><p>Heart failure occurs when the heart muscle is weak and unable to pump enough blood to supply the body&rsquo;s needs. B-COR&nbsp; is used to treat stable chronic heart failure.</p><p>It is used in combination with other medicines suitable for this condition (such as ACE-inhibitors, diuretics, and heart glycosides).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>A. Do not take B-COR if:</p><p>Do not take B-COR if one of the following conditions applies to you:</p><p>&bull; Allergy (hypersensitivity) to Bisoprolol or to any of the other ingredients (see section 6 &lsquo;What B-COR&nbsp; contains&rsquo;).</p><p>&bull; Severe asthma.</p><p>&bull; Severe blood circulation problems in your limbs (such as Raynaud&rsquo;s syndrome), which may cause your fingers and toes to tingle or turn pale or blue.</p><p>&bull; Untreated phaeochromocytoma, which is a rare tumour of the adrenal gland.</p><p>&bull; Metabolic acidosis, which is a condition when there is too much acid in the blood.</p><p>Do not take B-COR if you have one of the following heart problems:</p><p>&bull; Acute heart failure.</p><p>&bull; Worsening heart failure requiring injection of medicines into a vein, that increase the force of contraction of the heart.</p><p>&bull; Slow heart rate.</p><p>&bull; Low blood pressure.</p><p>&bull; Certain heart conditions causing a very slow heart rate or irregular heartbeat.</p><p>&bull; Cardiogenic shock, which is an acute serious heart condition causing low blood pressure and circulatory failure.</p><p>B. Take special care with B-COR:</p><p>If you have any of the following conditions tell your doctor before taking B-COR ; he or she may want to take special care (for example give additional treatment or perform more frequent checks):</p><p>&bull; Diabetes.</p><p>&bull; Strict fasting.</p><p>&bull; Certain heart diseases such as disturbances in heart rhythm, or severe chest pain at rest (Prinzmetal&rsquo;s angina).</p><p>&bull; Kidney or liver problems.</p><p>&bull; Less severe blood circulation problems in your limbs.</p><p>&bull; Chronic lung disease or less severe asthma.</p><p>&bull; History of a scaly skin rash (psoriasis).</p><p>&bull; Tumour of the adrenal gland (phaeochromocytoma).</p><p>&bull; Thyroid disorder.</p><p>In addition, tell your doctor if you are going to have:</p><p>&bull; Desensitization therapy (for example for the prevention of hay fever), because B-COR may make it more likely that you experience an allergic reaction, or such reaction may be more severe.</p><p>&bull; Anaesthesia (for example for surgery), because B-COR&nbsp; may influence how your body reacts to this situation.</p><p>If you have chronic lung disease or less severe asthma please inform your doctor immediately if you start to experience new difficulties in breathing, cough, wheezing after exercise, etc. when using B-COR .</p><p>Children and adolescents:</p><p>B-COR&nbsp; is not recommended for use in children or adolescents</p><p>C. Taking other medicines:</p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p>Do not take the following medicines with B-COR without special advice from your doctor:</p><p>&bull; Certain medicines used to treat irregular or abnormal heartbeat (Class I antiarrhythmic medicines such as quinidine, disopyramide, lidocaine, phenytoin; flecainide, propafenone).</p><p>&bull; Certain medicines used to treat high blood pressure, angina pectoris or irregular heartbeat (calcium antagonists such as verapamil and diltiazem).</p><p>&bull; Certain medicines used to treat high blood pressure such as clonidine, methyldopa, moxonodine, rilmenidine. However, do not stop taking these medicines without checking with your doctor first.</p><p>Check with your doctor before taking the following medicines with B-COR; your doctor may need to check your condition more frequently:</p><p>&bull; Certain medicines used to treat high blood pressure or angina pectoris (dihydropyridine-type calcium antagonists such as felodipine and amlodipine).</p><p>&bull; Certain medicines used to treat irregular or abnormal heartbeat (Class III antiarrhythmic medicines such as amiodarone).</p><p>&bull; Beta-blockers applied locally (such as timolol eye drops for glaucoma treatment).</p><p>&bull; Certain medicines used to treat for example Alzheimer&rsquo;s disease or glaucoma (parasympathomimetics such as tacrine or carbachol) or medicines that are used to treat acute heart problems (sympathomimetics such as isoprenaline and dobutamine).</p><p>&bull; Antidiabetic medicines including insulin.</p><p>&bull; Anaesthetic agents (for example during surgery).</p><p>&bull; Digitalis, used to treat heart failure.</p><p>&bull; Non-steroidal anti-inflammatory medicines (NSAIDs) used to treat arthritis, pain or inflammation (for example ibuprofen or diclofenac).</p><p>&bull; Any medicine, which can lower blood pressure as a desired or undesired effect such as antihypertensives, certain medicines for depression (tricyclic antidepressants such as imipramine or amitriptyline), certain medicines used to treat epilepsy or during anaesthesia (barbiturates such as phenobarbital), or certain medicines to treat mental illness characterized by a loss of contact with reality (phenothiazines such as levomepromazine)</p><p>&bull; Mefloquine, used for prevention or treatment of malaria</p><p>&bull; Depression treatment medicines called monoamine oxidase inhibitors (except MAO-B inhibitors) such as moclobemide.</p><p>D. Taking B-COR with food and drink:</p><p>Take the tablet with some water in the morning, with or without food. Do not crush or chew the tablet.</p><p>Treatment with B-COR&nbsp; is usually long-term.</p><p>E. Pregnancy and breast-feeding:</p><p>Pregnancy:</p><p>There is a risk that use of B-COR&nbsp; during pregnancy may harm the baby. If you are pregnant or planning to become pregnant, tell your doctor. He or she will decide whether you can take B-COR&nbsp; during pregnancy.</p><p>Breast-feeding:</p><p>It is not known whether Bisoprolol passes into human breast milk. Therefore, breastfeeding is not recommended during therapy with B-COR.</p><p>Ask your doctor or pharmacist for advice before taking any medicine.</p><p>F. Driving and using machines:</p><p>Your ability to drive or use machinery may be affected depending on how well you tolerate the medicine.</p><p>Please be especially cautious at the start of treatment, when the dose is increased or the medication is changed, as well as in combination with alcohol.</p><p>G. Important information about some of the ingredients of B-COR:</p><p>B-COR 10mg film coated tablet contains sunset yellow as a coloring agent which may cause allergic reactions.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</p><p>Treatment with B-COR&nbsp; requires regular monitoring by your doctor. This is particularly necessary at the start of treatment, during dose increase and when you stop treatment.</p><p>Take the tablet with some water in the morning, with or without food.</p><p>Do not crush or chew the tablet.</p><p>The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.</p><p>Treatment with B-COR&nbsp; is usually long-term.</p><p>Adults including the elderly:</p><p>Treatment with Bisoprolol must be started at a low dose and increased gradually.</p><p>Your doctor will decide how to increase the dose, and this will normally be done in the following way:</p><p>2.5mg Bisoprolol once daily for one week</p><p>5mg Bisoprolol once daily for four weeks</p><p>10mg Bisoprolol once daily for maintenance (ongoing) therapy.</p><p>The maximum recommended daily dose is 10mg Bisoprolol.</p><p>Depending on how well you tolerate the medicine, your doctor may also decide to lengthen the time between dose increases. If your condition gets worse or you no longer tolerate the drug, it may be necessary to reduce the dose again or to interrupt treatment. In some patients a maintenance dose lower than 10mg Bisoprolol may be sufficient.</p><p>Your doctor will tell you what to do.</p><p>If you have to stop treatment entirely, your doctor will usually advise you to reduce the dose gradually, as otherwise your condition may become worse.</p><p>A. If you take more B-COR than you should:</p><p>If you have taken more B-COR tablets than you should, tell your doctor immediately. Your doctor will decide what measures are necessary.</p><p>Symptoms of an overdose may include slowed heart rate, severe difficulty in breathing, feeling dizzy, or trembling (due to decreased blood sugar).</p><p>B. If you forget take B-COR:</p><p>Do not take a double dose to make up for a forgotten dose. Take your usual dose the next morning.</p><p>C. If you stop taking B-COR:</p><p>Never stop taking B-COR&nbsp; unless on your doctor&rsquo;s advice. Otherwise your condition could become much worse.</p><p>If you have any further questions on the use of this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>To prevent serious reactions, speak to a doctor immediately if a side effect is severe, occurred suddenly or gets worse rapidly.</p><p>The most serious side effects are related to the heart function:</p><p>&bull; Slowing of heart rate (may affect more than 1 in 10 people).</p><p>&bull; Worsening of heart failure (may affect up to 1 in 10 people).</p><p>&bull; Slow or irregular heartbeat (may affect up to 1 in 100 people).</p><p>If you feel dizzy or weak, or have breathing difficulties please contact your doctor as soon as possible.</p><p>Further side effects are listed below according to how frequently they may occur:</p><p>Common (may affect up to 1 in 10 people):</p><p>&bull; Tiredness, feeling weak, dizziness, headache.</p><p>&bull; Feeling of coldness or numbness in hands or feet.</p><p>&bull; Low blood pressure.</p><p>&bull; Stomach or intestine problems such as nausea, vomiting, diarrhoea, or constipation.</p><p>Uncommon (may affect up to 1 in 100 people):</p><p>&bull; Sleep disturbances.</p><p>&bull; Depression.</p><p>&bull; Dizziness when standing up.</p><p>&bull; Breathing problems in patients with asthma or chronic lung disease.</p><p>&bull; Muscle weakness, muscle cramps.</p><p>Rare (may affect up to 1 in 1,000 people):</p><p>&bull; Hearing problems.</p><p>&bull; Allergic runny nose.</p><p>&bull; Reduced tear flow.</p><p>&bull; Inflammation of the liver which can cause yellowing of the skin or whites of the eyes.</p><p>&bull; Certain blood test results for liver function or fat levels differing from normal.</p><p>&bull; Allergy-like reactions such as itching, flush, rash.</p><p>&bull; Impaired erection.</p><p>&bull; Nightmares, hallucinations.</p><p>&bull; Fainting.</p><p>Very rare (may affect up to 1 in 10,000 people):</p><p>&bull; Irritation and redness of the eye (conjunctivitis).</p><p>&bull; Hair loss.</p><p>&bull; Appearance or worsening of scaly skin rash (psoriasis); psoriasis-like rash.</p><p>If any of the side effects gets serious or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; Keep out of the reach and sight of children.</p><p>&bull; Do not use B-COR&nbsp; after the expiry date which is stated on the label and carton.</p><p>&bull; This medicinal product does not require any special storage conditions.</p><p>&bull; Do not use any B-COR&nbsp; pack that is damaged or shows signs of tampering.</p><p>&bull; Don&rsquo;t store above 30oC.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>B-COR 2.5 contains 2.5mg of Bisoprolol Fumarate.</p><p>B-COR 5 contains 5mg of Bisoprolol Fumarate.</p><p>B-COR 10 contains 10mg of Bisoprolol Fumarate.</p><p>The other ingredients are: Microcrystalline Cellulose / Dicalcium Phosphate / Crospovidone / Colloidal Silicon Dioxide / Magnesium Stearate /HPMC Hypromellose 5 CP / Glycerin / PEG 6000 / Talc / Titanium Dioxide.</p><p>B-Cor 5 also contains Red Oxide.</p><p>B-Cor 10 also contains Sunset Yellow Color.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Pharmaceutical form: Film Coated Tablet.
B-COR 2.5 pack size: 30 Film Coated Tablets.
B-COR 5 pack size: 30 Film Coated Tablets.
B-COR 10 pack size: 30 Film Coated Tablets.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Jordan Sweden Medical and Sterilization Company (Joswe-medical)</p><p>P.O. Box 851831 Amman 11185 Jordan</p><p>E-mail: joswe@go.com.jo</p><p>www.joswe.com</p><p>Tel: +962 6 5859765, +962 6 5728327</p><p>Fax: +962 6 5814526, +962 6 5728326</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last approved in 04/2022; Revision number R1.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي بيتا كور على المادة الفعالة بيسوبرولول.</p><p dir="RTL">ينتمي البيسوبرولول إلى مجموعة من الأدوية تسمى حاصرات بيتا. وتعمل هذه الأدوية عن طريق التأثير على استجابة الجسم لبعض الومضات العصبية، خصيصا في القلب. نتيجة لذلك، يعمل البيسوبرولول على تباطؤ سرعة القلب ويجعله أكثر كفائة في ضخ الدم حول الجسم.</p><p>يحدث الفشل القلبي عندما تكون عضلة القلب ضعيفة و ليس لديها القدرة على ضخ كمية كافية تغطي حاجة الجسم من الدم. يستخدم بيتا كور لعلاج الفشل القلبي المزمن الدائم. يستخدم بالتزامن مع أدوية أخرى ملائمة لعلاج هذه الحالة (مثل مثبطات ACE، مدرات البول، جلايكوسيدات القلب).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">أ. لا تتناول بيتا كور إذا:</p><p dir="RTL">لا تتناول بيتا كور إذا كان ينطبق عليك أي من الحالات التالية:</p><p dir="RTL">&bull; الحساسية (فرط الحساسية) ضد البيسوبرولول أو أي من المكونات الأخرى لهذا الدواء (انظر إلى القسم 6 &quot; ماذا يحتوي بيتا كور&quot;).</p><p dir="RTL">&bull; أزمة الربو الحادة.</p><p dir="RTL">&bull; مشاكل حادة في الدورة الدموية الواصلة للأطراف (مثل متلازمة راينود)، التي من الممكن أن تسبب وخز في أصابع اليد والقدم أو أن تجعلها&nbsp; شاحبة أو زرقاء اللون.</p><p dir="RTL">&bull; ورم نادر الحدوث في الغدة الكظرية.</p><p dir="RTL">&bull; عمليات الأيض الحمضية، وهي الحالة التي يكون فيها الدم يحتوي على كمية كبيرة من الحمض.</p><p dir="RTL">لا تتناول بيتا كور إذا كنت تعاني من أحد مشاكل القلب التالية:</p><p dir="RTL">&bull; الفشل القلبي الحاد.</p><p dir="RTL">&bull; الفشل القلبي المتفاقم، الذي يحتاج الى حقن دواء في الوريد، مما يزيد من قوة انقباض القلب.</p><p dir="RTL">&bull; تباطؤ في معدل نبضات القلب.</p><p dir="RTL">&bull; ضغط الدم المنخفض.</p><p dir="RTL">&bull;حالات معينة تصيب القلب تسبب تباطؤ في سرعة القلب أو نبض قلب غير منتظم.</p><p dir="RTL">&bull; الصدمة القلبية، وهي حالة خطيرة وحادة تصيب القلب وتسبب انخفاض ضغط الدم وفشل في الدورة الدموية.</p><p dir="RTL">ب. أخذ الحيطة والحذر عند تناول بيتا كور:</p><p dir="RTL">قم بإخبار الطبيب أو الصيدلي إذا كنت تعاني من أي من الحالات التالية قبل تناول بيتا كور، لأنه من الممكن أن تكون بحاجة إلى رعاية خاصة (على سبيل المثال اعطاء علاج إضافي أو إجراء فحوصات دورية بشكل أكثر تكرارا):</p><p dir="RTL">&bull; مرض السكري.</p><p dir="RTL">&bull; الصيام الصارم.</p><p dir="RTL">&bull; أمراض قلب معينة مثل اضطراب ضربات القلب، ألم صدري حاد في وقت الراحة (الذبحة الصدرية برينزميتال).</p><p dir="RTL">&bull; مشاكل في الكلى أو الكبد.</p><p dir="RTL">&bull; مشاكل أقل خطورة في الدورة الدموية الواصلة للأطراف.</p><p dir="RTL">&bull; مرض مزمن في الرئتين أو أزمة ربو قليلة الحدة.</p><p dir="RTL">&bull; تاريخ مرضي بالإصابة بطفح جلدي متقشر (مرض الصدفية).</p><p dir="RTL">&bull; ورم في الغدة الكظرية.</p><p dir="RTL">&bull; اضطراب في الغدة الدرقية.</p><p dir="RTL">بالإضافة إلى ذلك، عليك إخبار الطبيب إذا كنت ستأخذ أي من الأمور التالية:</p><p dir="RTL">&bull; علاج ضد الحساسية (على سبيل المثال لمنع الإصابة بحمى القش)، لأن بيتا كور من الممكن أن يجعلك أكثر عرضة للإصابة بتفاعلات تحسسية، أو أن يجعل هذه التفاعلات التحسسية أكثر حدة.</p><p dir="RTL">&bull; التخدير( على سبيل المثال لإجراء عملية جراحية)، لأن من الممكن أن يؤثر بيتا كور على آلية استجابة جسمك لمثل هذه الأوضاع.</p><p dir="RTL">إذا كنت تعاني من مرض مزمن في الرئة أو مرض ربو قليل الحدة، وعند استخدامك بيتا كور بدأت بالمعاناة من صعوبات جديدة في التنفس، السعال، الصفير بعد ممارسة التمارين الرياضية،....الخ. يرجى إعلام الطبيب فورا˝.</p><p dir="RTL">الأطفال والمراهقين:</p><p dir="RTL">لا ينصح باستخدام بيتا كور من قبل الأطفال والمراهقين.</p><p dir="RTL">ج. تناول أدوية أخرى:</p><p dir="RTL">إذا كنت تتناول أو تناولت حديثا أو من الممكن أن تتناول أي أدوية أخرى يرجى إعلام الطبيب أو الصيدلاني بذلك.</p><p dir="RTL">لا تتناول الأدوية التالية مع بيتا كور، بدون نصيحة خاصة تسدى اليك من قبل طبيبك:</p><p dir="RTL">&bull; أدوية معينة تستخدم لعلاج نبض القلب غير الطبيعي أو غير المنتظم (النوع الأول من الأدوية المضادة لاضطراب النظم مثل كوينيدين، ديسوبيراميد، ليدوكين، فينيتوين، فلاسينايد بروبافينون).</p><p dir="RTL">&bull; أدوية معينة تستخدم لعلاج ضغط الدم المرتفع، الذبحة الصدرية أو نبض القلب غير المنتظم (مضادات الكالسيوم مثل الفيراباميل والديلتيازم).</p><p dir="RTL">&bull; أدوية معينة تستخدم لعلاج ضغط الدم المرتفع مثل كلونيدين، ميثيلدوبا، موكسونيدين، ريلمينيدين. على الرغم من ذلك، لا تتوقف عن تناول هذه الأدوية إلا بعد إستشارة طبيبك.</p><p dir="RTL">يجب إستشارة طبيبك قبل تناولك الأدوية التالية مع بيتا كور، لأنه من الممكن أن يحتاج الطبيب لإجراء فحوصات دورية لك بشكل أكثر تكرارا:</p><p dir="RTL">&bull; أدوية معينة تستخدم لعلاج ضغط الدم المرتفع، الذبحة الصدرية (ديهايدروبيريدين-أحد أنواع مضادات الكالسيوم مثل فيلوديبين وأملوديبين).&nbsp;</p><p dir="RTL">&bull; حاصرات بيتا للإستخدامات الموضعية (مثل قطرة العين تيمولول المستخدمة لعلاج الزّرق).</p><p dir="RTL">&bull; أدوية معينة تستخدم على سبيل المثال لعلاج مرض الزهايمر أو الزّرق (محاكي لاودّي مثل تاكرين أو كارباكول) أو الأدوية المستخدمة لعلاج مشاكل القلب الحادة (محاكي ودّي مثل أيزوبرينالين ودوباتامين).</p><p dir="RTL">&bull; الأدوية المضادة للسكري وتشمل الأنسولين.</p><p dir="RTL">&bull; عوامل التخدير (على سبيل المثال خلال العمليات الجراحية).</p><p dir="RTL">&bull; دييجيتاليس، يستخدم في علاج مرض الفشل القلبي.</p><p dir="RTL">&bull; أدوية مضادات الإلتهاب غير الإستيرويدية (NSAIDs)، المستخدمة في علاج التهاب المفاصل، الإحساس بالألم أو الإلتهاب (على سبيل المثال أيبوبروفين أو ديكلوفيناك).</p><p dir="RTL">&bull; أي دواء، من الممكن أن يسبب انخفاض في ضغط الدم سواء كان بتأثير مرغوب أو غير مرغوب به مثل الأدوية المضادة لارتفاع ضغط الدم، أدوية معينة تستخدم في حالة الإكتئاب (مضادات الإكتئاب ثلاثية الحلقات مثل الإيميبرامين أو الأميتريبتيلين)، أدوية معينة تستخدم لعلاج مرض الصرع أو خلال عمليات التخدير (باربيوتيريت مثل فينوباربيتال)، أو أدوية معينة تستخدم لعلاج الأمراض العقلية التي تتميز بفقدان التواصل مع الواقع (فينوثيازين مثل ليفوميبرومازين).</p><p dir="RTL">&bull; ميفلوكوين، المستخدم لمنع الإصابة بالملاريا أو لعلاجها.</p><p dir="RTL">&bull; أدوية علاج الإكتئاب التي تسمى مثبطات أنزيم مؤكسد أحادي الأمين (بإستثناء مثبطات MAO-B) مثل موكلوبيمايد.</p><p dir="RTL">د. تناول بيتا كور مع الطعام والشراب :</p><p dir="RTL">تناول الحبة في الصباح مع شرب كمية من الماء، مع الطعام أو بدونه. لا تقم بمضغ الحبة أو تحطيمها.</p><p dir="RTL">العلاج بإستخدام بيتا كور يكون في العادة لمدة زمنية طويلة.</p><p dir="RTL">ه.&nbsp; الحمل والإرضاع:</p><p dir="RTL">الحمل:</p><p dir="RTL">هناك خطر من إستخدام بيتا كورخلال فترة الحمل لأنه من الممكن أن يلحق الضرر بالجنين. يرجى إعلام الطبيب في حالة الحمل أو التخطيط للإنجاب. فهو الذي يقرر إذا كان من الممكن أن تتناولي بيتا كور خلال فترة الحمل.</p><p dir="RTL">الرضاعة الطبيعية:</p><p dir="RTL">إنه من غير المعروف إذا كان بيسوبرولول يدخل في حليب الثدي أو لا. وبتالي لا ينصح بالرضاعة الطبيعية خلال فترة العلاج باستخدام بيتا كور.</p><p dir="RTL">قم بإستشارة طبيبك أو الصيدلي قبل تناولك لأي دواء.</p><p dir="RTL">و. القيادة وتشغيل الآلات:</p><p dir="RTL">ستتأثر قدرتك على القيادة أو إستخدام الآلات بالإعتماد على قدرة تحملك لهذا الدواء.</p><p dir="RTL">يرجى مراعاة الحذر الشديد عند البدأ بتناولك لهذا الدواء أو إذا زادت الجرعة أو تم تغيير الدواء، أو إذا كنت تتناول الكحول.</p><p dir="RTL">ز.معلومات مهمة عن بعض مكونات بيتا كور:</p><p dir="RTL">يحتوي بيتا كور 10ملغم أقراص مغلفة غشائياً على Sunset Yellow كمادة ملونة، الذي من الممكن أن يسبب تفاعلات تحسسية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">دائما قم بتناول بيتا كور تماما كما أخبرك الطبيب أو الصيدلي. اذا كنت غير متأكد بامكانك الرجوع الى الطبيب أو الصيدلي.</p><p dir="RTL">العلاج باستخدام بيتا كور يحتاج إلى مراقبة دورية من قبل طبيبك. خصيصا عند بدء العلاج، خلال زيادة الجرعة أوعند ايقاف العلاج.</p><p dir="RTL">تناول الحبة في الصباح مع شرب كمية من الماء، مع الطعام أو بدونه. لا تقم بمضغ الحبة أو تحطيمها.</p><p dir="RTL">الخط المنقوش على قرص الدواء هو فقط لمساعدتك على كسر القرص لتسهيل ابتلاعه وليس لتجزئة القرص إلى جرعتين متساويتين.</p><p dir="RTL">العلاج بإستخدام بيتا كور يكون في العادة لمدة زمنية طويلة.</p><p dir="RTL">البالغين ومن ضمنهم كبار السن:</p><p dir="RTL">العلاج باستخدام بيتا كور يجب أن يبدء بجرعة منخفضة وتزيد تدريجيا˝.</p><p dir="RTL">الطبيب هو الذي يقرر كيفية زيادة الجرعة، وتتم عادة بإتباع الطريقة التالية:</p><p dir="RTL">2.5ملغم بيسوبرولول مرة يومياً لمدة أسبوع واحد.</p><p dir="RTL">5ملغم بيسوبرولول مرة يومياً لمدة أربعة أسابيع.</p><p dir="RTL">10ملغم بيسوبرولول مرة يومياً كجرعة داعمة (مستمرة).</p><p dir="RTL">الحد الأقصى للجرعة المسموح بها هو 10ملغم بيسوبرولول.</p><p dir="RTL">وهذا يعتمد على قدرة تحملك لهذا الدواء، ومن الممكن أن يقرر الطبيب بأن يزيد من طول الفترات ما بين زيادة الجرعة. إذا تفاقمت حالتك أو أصبحت غير قادر على تحمل الدواء، فمن الضروري أن يقوم الطبيب بتقليل الجرعة أو التدخل في العلاج. جرعة أقل من 10ملغم بيسوبرولول كجرعة داعمة قد تكون كافية لبعض المرضى.</p><p dir="RTL">سيقوم الطبيب بإخبارك بما يتوجب عليك فعله.</p><p dir="RTL">إذا كان من الواجب عليك ايقاف الجرعة، فسوف ينصحك الطبيب بتقليل الجرعة تدريجيا˝، وإلاّ من الممكن أن تتفاقم حالتك.</p><p dir="RTL">أ. اذا كنت تتناول جرعة بيتا كور أكثر من اللازم:</p><p dir="RTL">يجب أن تقوم بإخبار طبيبك فورا˝، في حالة تناولك لأقراص بيتا كور أكثر من اللازم. الطبيب هو من يقرر ما هي الإجراءات اللازمة.</p><p dir="RTL">أعراض زيادة الجرعة من الممكن أن تشمل تباطؤ في نبضات القلب، صعوبات حادة في التنفس، الشعور بالدوار، أو الشعور بالإرتعاش (بسبب إنخفاض في سكر الدم).</p><p dir="RTL">ب. إذا نسيت تناول بيتا كور:</p><p dir="RTL">لا تقم بمضاعفة الجرعة لتغطية الجرعة المنسيّة. قم بتناول الجرعة المعتادة في صباح اليوم التالي.</p><p dir="RTL">ج. إذا توقفت عن تناول بيتا كور:</p><p dir="RTL">لا تتوقف أبداً عن تناول بيتا كور إلا بنصيحة من الطبيب، وإلاّ فمن الممكن أن تصبح حالتك أكثر سوءاً.</p><p>قم بسؤال طبيبك أو الصيدلي، إذا كان لديك أي أسئلة أخرى حول استخدام هذا المستحضر.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، يمكن لهذا الدواء أن يسبب آثار جانبية على الرغم من عدم حدوثها لدى الجميع.</p><p dir="RTL">لمنع حدوث أي تفاعلات خطيرة، قم بالتحدث فوراُ إلى طبيبك إذا كان هذا العرض الجانبي خطير، حدث فجأة، أو تفاقم بسرعة.</p><p dir="RTL">معظم الأعراض الجانبية الخطيرة تكون متعلقة بوظيفة القلب:</p><p dir="RTL">&bull; تباطؤ سرعة القلب (من الممكن أن يصيب أكثر من شخص لكل 10 أشخاص).</p><p dir="RTL">&bull; تفاقم في الفشل القلبي (من الممكن أن يصيب لغاية شخص لكل 10 أشخاص).</p><p dir="RTL">&bull; تباطؤ أو عدم انتظام في نبضات القلب (من الممكن أن يصيب لغاية شخص لكل 100 شخص).</p><p dir="RTL">يرجى التواصل مع طبيبك في أقرب وقت ممكن في حالة شعورك&nbsp; بالدوار أو التعب، أو إذا كان لديك صعوبات في التنفس.</p><p dir="RTL">هناك أعراض جانبية&nbsp; أخرى مذكورة أدناه بالإعتماد على مدى تكرار حدوثها:</p><p dir="RTL">الشائعة (من الممكن أن تصيب لغاية شخص لكل 10 أشخاص):</p><p dir="RTL">&bull; الإرهاق، الشعور بالتعب، الدوار، الصداع.</p><p dir="RTL">&bull; الشعور بالبرودة أو خدر في الأيدي والأقدام.</p><p dir="RTL">&bull; إنخفاض في ضغط الدم.</p><p dir="RTL">&bull; مشاكل في المعدة أو الأمعاء مثل الشعور بالغثيان، الإستفراغ، الإسهال، أو الإمساك.</p><p dir="RTL">غير شائعة (من الممكن أن تصيب لغاية شخص لكل 100 شخص):</p><p dir="RTL">&bull; إضطرابات في النوم.</p><p dir="RTL">&bull; الإكتئاب.</p><p dir="RTL">&bull; الشعور بالدوار عند الوقوف.</p><p dir="RTL">&bull; مشاكل تنفسية عند الأشخاص المصابين بالربو أو مرض مزمن في الرئة.</p><p dir="RTL">&bull; ضعف في العضلات، تشنجات في العضلات.</p><p dir="RTL">نادرة الحدوث (تصيب لغاية شخص لكل 1,000 شخص):</p><p dir="RTL">&bull;&nbsp; مشاكل سمعية.</p><p dir="RTL">&bull; سيلان الأنف التحسسي.</p><p dir="RTL">&bull; إنخفاض&nbsp; جريان الدمع.</p><p dir="RTL">&bull; التهاب في الكبد من الممكن أن يؤدي إلى إصفرار في الجلد أو بياض العين.</p><p dir="RTL">&bull; تغيير في بعض نتائج فحوصات الدم المتعلقة بوظيفة الكبد أو مستوى الدهون عن الطبيعي.</p><p dir="RTL">&bull;&nbsp; تفاعلات مشابهة للحساسية مثل الحكة، إحمرار الوجه، الطفح الجلدي.</p><p dir="RTL">&bull; ضعف في الانتصاب.</p><p dir="RTL">&bull; كوابيس، هلوسة.</p><p dir="RTL">&bull; إغماء.</p><p dir="RTL">نادرة جدا (من الممكن أن تصيب لغاية شخص لكل 10,000 شخص):</p><p dir="RTL">&bull; إحمرار وتهيج في العين (التهاب الملتحمة).</p><p dir="RTL">&bull; تساقط الشعر.</p><p dir="RTL">&bull; ظهور طفح جلدي متقشر أو تفاقمه (مرض الصدفية)، طفح شبيه بالصدفية.</p><p dir="RTL">اذا زادت حدة أحد هذه الأعراض الجانبية، أو لاحظت أي أعراض جانبية لم يرد ذكرها في هذه النشرة، يرجى إخبار الطبيب أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&bull; يحفظ بعيدا˝ عن متناول الأطفال.</p><p dir="RTL">&bull; لا تستخدم بيتا كور بعد انتهاء فترة الصلاحية&nbsp; المذكورة على اللاصق الداخلي و العبوة الخارجية.</p><p dir="RTL">&bull; لا يحتاج هذا المنتج الطبي إلى ظروف تخزين خاصة.</p><p dir="RTL">&bull; لا تستخدم بيتا كور عند ملاحظة أي علامة تلف عليه.</p><p>&bull; لا يحفظ في درجة حرارة تزيد عن o30م.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">بيتا كور 2.5&nbsp; يحتوي على 2.5ملغم من بيسوبرولول فومارات.</p><p dir="RTL">بيتا كور 5ملغم يحتوي على 5ملغم من بيسوبرولول فومارات.</p><p dir="RTL">بيتا كور 10ملغم يحتوي على 10ملغم من بيسوبرولول فومارات.</p><p dir="RTL">المكونات الأخرى هي: مايكروكريستالين سيليولوز/ فوسفات ثنائي الكالسيوم/ كروسبوفيدون/ ثنائي أكسيد السيليكون الغروية/ مغنيسيوم ستيريت/ لستر كلير (مايكروكريستالين سيليولوز، كاراجينان، كلايجول متعدد الايثيلين)/ ثنائي أكسيد التيتانيوم.</p><p dir="RTL">بيتا كور 5 يحتوي أيضاً على الأكسيد الأحمر.</p><p dir="RTL">بيتا كور 10&nbsp; يحتوي أيضاً على لون أصفر (Sunset Yellow).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">ب. ما هو شكل بيتا كور:</p><p dir="RTL">الشكل الصيدلاني: أقراص مغلفة غشائيا˝.</p><p dir="RTL">سعة عبوة بيتا كور 2.5: 30 قرص مغلف غشائيا˝.</p><p dir="RTL">سعة عبوة بيتا كور 5: 30 قرص مغلف غشائيا˝.</p><p>سعة عبوة بيتا كور 10: 30 قرص مغلف غشائيا˝ .</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">الشركة الأردنية السويدية للمنتجات الطبية و التعقيم.</p><p dir="RTL">صندوق بريد 851831&nbsp; عمان 11185&nbsp; الأردن</p><p dir="RTL">الايميل: joswe@go.com.jo</p><p dir="RTL">www.joswe.com</p><p dir="RTL">هاتف: +962 6 5728327 ،+962 6 5859765</p><p dir="RTL">فاكس:&nbsp; +962 6 5728326 ،+962 6 5814526</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
             تمت مراجعة هذه النشرة في  2017/5؛ رقم المراجعة R0
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                B-Cor® 2.5mg Film Coated Tablet
B-Cor® 5mg Film Coated Tablet
B-Cor® 10mg Film Coated Tablet
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                B-Cor 2.5mg Film Coated Tablet: One tablet contains 2.5mg of Bisoprolol Fumarate 
B-Cor 5mg Film Coated Tablet: One tablet contains 5mg of Bisoprolol Fumarate 
B-Cor 10mg Film Coated Tablet: One tablet contains 10mg of Bisoprolol Fumarate

For a full list of excipients, see section 6.1

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film Coated Tablet
For B-Cor 2.5:
White film coated caplet bisected from one side.
For B-Cor 5:
Reddish pink Round Tablet, imposed with  from one side and scored from the other side with β5 embossment
For B-Cor 10: Orange Round Tablets, embossed with  from one side and scored from the other side with β 10 embossment

The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment of stable chronic heart failure with reduced systolic left ventricular function in addition to ACE inhibitors, and diuretics, and optionally cardiac glycosides.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Standard treatment of CHF consists of an ACE inhibitor (or an angiotensin receptor blocker in case of intolerance to ACE inhibitors), a beta-blocker, diuretics, and when appropriate cardiac glycosides. Patients should be stable (without acute failure) when Bisoprolol treatment is initiated.</p><p>It is recommended that the treating physician should be experienced in the management of chronic heart failure.</p><p>Transient worsening of heart failure, hypotension, or bradycardia may occur during the titration period and thereafter.</p><p>Posology</p><p>Titration phase</p><p>The treatment of stable chronic heart failure with Bisoprolol requires a titration phase the treatment with Bisoprolol is to be started with a gradual up titration according to the following steps:</p><p>&bull; 2.5 mg once daily for a further week, if well tolerated increase to</p><p>&bull; 5 mg once daily for the 4 following weeks, if well tolerated increase to</p><p>&bull; 10 mg once daily for the maintenance therapy.</p><p>The maximum recommended dose is 10 mg once daily. Close monitoring of vital signs (heart rate, blood pressure) and symptoms of worsening heart failure is recommended during the titration phase. Symptoms may already occur within the first day after initiating the therapy.</p><p>Treatment modification</p><p>If the maximum recommended dose is not well tolerated, gradual dose reduction may be considered. In case of transient worsening of heart failure, hypotension, or bradycardia reconsideration of the dosage of the concomitant medication is recommended. It may also be necessary to temporarily lower the dose of Bisoprolol or to consider discontinuation. The reintroduction and/or up titration of Bisoprolol should always be considered when the patient becomes stable again. If discontinuation is considered, gradual dose decrease is recommended, since abrupt withdrawal may lead to acute deterioration of the patient&rsquo;s condition. Treatment of stable chronic heart failure with Bisoprolol is generally a long-term treatment.</p><p>Patients with hepatic or renal impairment</p><p>There is no information regarding pharmacokinetics of Bisoprolol in patients with chronic heart failure and with impaired hepatic or renal function. Up titration of the dose in these populations should therefore be made with additional caution.</p><p>Older people</p><p>No dosage adjustment is required.</p><p>Paediatric population</p><p>There is no paediatric experience with Bisoprolol, therefore its use cannot be recommended in paediatric patients.</p><p>Method of administration</p><p>Bisoprolol tablets should be taken in the morning and can be taken with food. They should be swallowed with liquid and should not be chewed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Bisoprolol is contraindicated in chronic heart failure patients with:
• Acute heart failure or during episodes of heart failure decompensation requiring i.v. inotropic therapy 
• Cardiogenic shock
• Second- or third-degree AV block 
• Sick sinus syndrome 
• sinoatrial block 
• Symptomatic bradycardia 
• Symptomatic hypotension 
• Severe bronchial asthma 
• Severe forms of peripheral arterial occlusive disease or severe forms of Raynaud's syndrome 
• Untreated phaeochromocytoma (see section 4.4)
• Metabolic acidosis 
• Hypersensitivity to Bisoprolol or to any of the excipients listed in section 6.1
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The treatment of stable chronic heart failure with Bisoprolol has to be initiated with a special titration phase.</p><p>Especially in patients with ischaemic heart disease the cessation of therapy with Bisoprolol must not be done abruptly unless clearly indicated, because this may lead to transitional worsening of heart condition.</p><p>The initiation and cessation of treatment with Bisoprolol necessitates regular monitoring.</p><p>There is no therapeutic experience of Bisoprolol treatment of heart failure in patients with the following diseases and conditions:</p><p>&bull; Insulin dependent diabetes mellitus (type I)</p><p>&bull; Severely impaired renal function</p><p>&bull; Severely impaired hepatic function</p><p>&bull; Restrictive cardiomyopathy</p><p>&bull; Congenital heart disease</p><p>&bull; haemodynamically significant organic valvular disease</p><p>&bull; Myocardial infarction within 3 months</p><p>Bisoprolol must be used with caution in:</p><p>&bull; Bronchospasm (bronchial asthma, obstructive airways diseases)</p><p>&bull; Diabetes mellitus with large fluctuations in blood glucose values; Symptoms of hypoglycaemia can be masked</p><p>&bull; Strict fasting</p><p>&bull; Ongoing desensitisation therapy. As with other beta-blockers, Bisoprolol may increase both the sensitivity towards allergens and the severity of anaphylactic reactions. Epinephrine treatment does not always yield the expected therapeutic effect.</p><p>&bull; First degree AV block</p><p>&bull; Prinzmetal&#39;s angina</p><p>&bull; Peripheral arterial occlusive disease. Aggravation of symptoms may occur especially when starting therapy.</p><p>&bull; General anaesthesia.</p><p>In patients undergoing general anaesthesia beta-blockade reduces the incidence of arrhythmias and myocardial ischemia during induction and intubation, and the post-operative period. It is currently recommended that maintenance beta-blockade be continued peri-operatively. The anaesthesist must be aware of beta-blockade because of the potential for interactions with other drugs, resulting in bradyarrhythmias, attenuation of the reflex tachycardia and the decreased reflex ability to compensate for blood loss. If it is thought necessary to withdraw beta-blocker therapy before surgery, this should be done gradually and completed about 48 hours before anaesthesia.</p><p>Combination of Bisoprolol with calcium antagonists of the verapamil or diltiazem type, with Class I antiarrhytmic drugs and with centrally acting antihypertensive drugs is generally not recommended.</p><p>Although cardioselective (beta1) beta-blockers may have less effect on lung function than non-selective beta-blockers, as with all beta-blockers, these should be avoided in patients with obstructive airways diseases, unless there are compelling clinical reasons for their use.</p><p>Where such reasons exist, B-Cor may be used with caution. In patients with obstructive airways diseases, the treatment with Bisoprolol should be started at the lowest possible dose and patients should be carefully monitored for new symptoms (e.g. dyspnea, exercise intolerance, cough). In bronchial asthma or other chronic obstructive lung diseases, which may cause symptoms, bronchodilating therapy should be given concomitantly. Occasionally an increase of the airway resistance may occur in patients with asthma, therefore the dose of beta2-stimulants may have to be increased.</p><p>Patients with psoriasis or with a history of psoriasis should only be given beta-blockers (e.g. Bisoprolol) after carefully balancing the benefits against the risks.</p><p>In patients with phaeochromocytoma Bisoprolol must not be administered until after alpha-receptor blockade.</p><p>Under treatment with Bisoprolol the symptoms of a thyreotoxicosis may be masked.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Combinations not recommended</p><p>Calcium antagonists of the verapamil type and to a lesser extent of the diltiazem type: Negative influence on contractility and atrio-ventricular conduction. Intravenous administration of verapamil in patients on &beta;-blocker treatment may lead to profound hypotension and atrioventricular block.</p><p>Class I antiarrhythmic drugs (e.g. quinidine, disopyramide; lidocaine, phenytoin; flecainide, propafenone): Effect on atrio-ventricular conduction time may be potentiated and negative inotropic effect increased.</p><p>Centrally acting antihypertensive drugs such as clonidine and others (e.g. methyldopa, moxonodine, rilmenidine): Concomitant use of centrally acting antihypertensive drugs may worsen heart failure by a decrease in the central sympathetic tonus (reduction of heart rate and cardiac output, vasodilation). Abrupt withdrawal, particularly if prior to beta-blocker discontinuation, may increase risk of &ldquo;rebound hypertension&rdquo;.</p><p>Combinations to be used with caution</p><p>Calcium antagonists of the dihydropyridine type such as felodipine and amlodipine:</p><p>Concomitant use may increase the risk of hypotension, and an increase in the risk of a further deterioration of the ventricular pump function in patients with heart failure cannot be excluded.</p><p>Class-III antiarrhythmic drugs (e.g. amiodarone): Effect on atrio-ventricular conduction time may be potentiated.</p><p>Topical beta-blockers (e.g. eye drops for glaucoma treatment) may add to the systemic effects of Bisoprolol.</p><p>Parasympathomimetic drugs: Concomitant use may increase atrio-ventricular conduction time and the risk of bradycardia.</p><p>Insulin and oral antidiabetic drugs: Increase of blood sugar lowering effect. Blockade of beta-adrenoreceptors may mask symptoms of hypoglycaemia.</p><p>Anaesthetic agents: Attenuation of the reflex tachycardia and increase of the risk of hypotension (for further information on general anaesthesia see also section 4.4.).</p><p>Digitalis glycosides: Reduction of heart rate, increase of atrio-ventricular conduction time.</p><p>Non-steroidal anti-inflammatory drugs (NSAIDs): NSAIDs may reduce the hypotensive effect of Bisoprolol.</p><p>&beta;-Sympathomimetic agents (e.g. isoprenaline, dobutamine): Combination with Bisoprolol may reduce the effect of both agents.</p><p>Sympathomimetics that activate both &beta;- and &alpha;-adrenoceptors (e.g. noradrenaline, adrenaline): Combination with Bisoprolol may unmask the &alpha;-adrenoceptor-mediated vasoconstrictor effects of these agents leading to blood pressure increase and exacerbated intermittent claudication.</p><p>Such interactions are considered to be more likely with nonselective &beta;-blockers.</p><p>Concomitant use with antihypertensive agents as well as with other drugs with blood pressure lowering potential (e.g. tricyclic antidepressants, barbiturates, phenothiazines) may increase the risk of hypotension.</p><p>Combinations to be considered</p><p>Mefloquine: increased risk of bradycardia</p><p>Monoamine oxidase inhibitors (except MAO-B inhibitors): Enhanced hypotensive effect of the beta-blockers but also risk for hypertensive crisis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy</p><p>Bisoprolol has pharmacological effects that may cause harmful effects on pregnancy and/or the fetus/newborn, US FDA pregnancy category: C. In general, beta-adrenoceptor blockers reduce placental perfusion, which has been associated with growth retardation, intrauterine death, abortion or early labour. Adverse effects (e.g. hypoglycaemia and bradycardia) may occur in the fetus and newborn infant. If treatment with beta-adrenoceptor blockers is necessary, beta1-selective adrenoceptor blockers are preferable.</p><p>Bisoprolol should not be used during pregnancy unless clearly necessary. If treatment with Bisoprolol is considered necessary, the uteroplacental blood flow and the fetal growth should be monitored. In case of harmful effects on pregnancy or the fetus alternative treatment should be considered. The newborn infant must be closely monitored. Symptoms of hypoglycaemia and bradycardia are generally to be expected within the first 3 days.</p><p>Breast-feeding</p><p>It is not known whether this drug is excreted in human milk. Therefore, breastfeeding is not recommended during administration of Bisoprolol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In a study with coronary heart disease patients Bisoprolol did not impair driving performance. However, due to individual variations in reactions to the drug, the ability to drive a vehicle or to operate machinery may be impaired. This should be considered particularly at start of treatment and upon change of medication as well as in conjunction with alcohol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following definitions apply to the frequency terminology used hereafter:</p><p>Very common (&ge; 1/10)</p><p>Common (&ge; 1/100 to &lt; 1/10)</p><p>Uncommon (&ge; 1/1,000 to &lt; 1/100)</p><p>Rare (&ge; 1/10,000 to &lt; 1/1,000)</p><p>Very rare (&lt; 1/10,000)</p><p>Frequency not known (cannot be estimated from available data)</p><p>Cardiac disorders:<br />Very common: bradycardia.<br />Common: worsening of heart failure.<br />Uncommon: AV-conduction disturbances.</p><p>Investigations:<br />Rare: increased triglycerides, increased liver enzymes (ALAT, ASAT).</p><p>Nervous system disorders:<br />Common: dizziness, headache.</p><p>Rare: syncope</p><p>Eye disorders:<br />Rare: reduced tear flow (to be considered if the patient uses lenses).<br />Very rare: conjunctivitis.</p><p>Ear and labyrinth disorders:<br />Rare: hearing disorders.</p><p>Respiratory, thoracic and mediastinal disorders:<br />Uncommon: bronchospasm in patients with bronchial asthma or a history of obstructive airways disease.<br />Rare: allergic rhinitis.</p><p>Gastrointestinal disorders:<br />Common: gastrointestinal complaints such as nausea, vomiting, diarrhoea, constipation.</p><p>Skin and subcutaneous tissue disorders:<br />Rare: hypersensitivity reactions (itching, flush, rash).<br />Very rare: alopecia. Beta-blockers may provoke or worsen psoriasis or induce psoriasis-like rash</p><p>Musculoskeletal and connective tissue disorders:<br />Uncommon: muscular weakness and cramps.</p><p>Vascular disorders:<br />Common: feeling of coldness or numbness in the extremities, hypotension.<br />Uncommon: orthostatic hypotension.</p><p>General disorders:<br />Common: asthenia, fatigue.</p><p>Hepatobiliary disorders:<br />Rare: hepatitis.</p><p>Reproductive system and breast disorders:<br />Rare: potency disorders.</p><p>Psychiatric disorders:<br />Uncommon: sleep disorders, depression.</p><p>Rare: nightmares, hallucinations.</p><p>To reports any side effect (s):<br />Contact JOSWE Medical:</p><p>Saudipv@josweplant.com</p><p>The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />o Toll free phone: 8002490000<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptoms</p><p>With overdose (e.g. daily dose of 15 mg instead of 7.5 mg) third degree AV-block, bradycardia, and dizziness have been reported. In general the most common signs expected with overdosage of a beta-blocker are bradycardia, hypotension, bronchospasm, acute cardiac insufficiency and hypoglycaemia. To date a few cases of overdose (maximum: 2000 mg) with Bisoprolol have been reported in patients suffering from hypertension and/or coronary heart disease showing bradycardia and/or hypotension; all patients recovered. There is a wide interindividual variation in sensitivity to one single high dose of Bisoprolol and patients with heart failure are probably very sensitive. Therefore it is mandatory to initiate the treatment of these patients with a gradual uptitration according to the scheme given in section 4.2.</p><p>Management</p><p>If overdose occurs, Bisoprolol treatment should be stopped and supportive and symptomatic treatment should be provided. Limited data suggest that Bisoprolol is hardly dialysable. Based on the expected pharmacologic actions and recommendations for other beta-blockers, the following general measures should be considered when clinically warranted.</p><p>Bradycardia: Administer intravenous atropine. If the response is inadequate, isoprenaline or another agent with positive chronotropic properties may be given cautiously. Under some circumstances, transvenous pacemaker insertion may be necessary.</p><p>Hypotension: Intravenous fluids and vasopressors should be administered. Intravenous glucagon may be useful.</p><p>AV block (second or third degree): Patients should be carefully monitored and treated with isoprenaline infusion or transvenous cardiac pacemaker insertion.</p><p>Acute worsening of heart failure: Administer i.v. diuretics, inotropic agents, vasodilating agents.</p><p>Bronchospasm: Administer bronchodilator therapy such as isoprenaline, beta2-sympathomimetic drugs and/or aminophylline.</p><p>Hypoglycaemia: Administer i.v. glucose.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Beta blocking agents, selective</p><p>ATC Code: C07AB07</p><p>Mechanism of action</p><p>Bisoprolol is a highly beta1-selective-adrenoceptor blocking agent, lacking intrinsic stimulating and relevant membrane stabilising activity. It only shows low affinity to the beta2-receptor of the smooth muscles of bronchi and vessels as well as to the beta2-receptors concerned with metabolic regulation. Therefore, Bisoprolol is generally not to be expected to influence the airway resistance and beta2-mediated metabolic effects. Its beta1-selectivity extends beyond the therapeutic dose range.</p><p>Clinical efficacy and safety</p><p>In total 2647 patients were included in the CIBIS II trial. 83% (n = 2202) were in NYHA class III and 17% (n = 445) were in NYHA class IV. They had stable symptomatic systolic heart failure (ejection fraction &lt;35%, based on echocardiography). Total mortality was reduced from 17.3% to 11.8% (relative reduction 34%). A decrease in sudden death (3.6% vs 6.3%, relative reduction 44%) and a reduced number of heart failure episodes requiring hospital admission (12% vs 17.6%, relative reduction 36%) was observed. Finally, a significant improvement of the functional status according to NYHA classification has been shown. During the initiation and titration of Bisoprolol hospital admission due to bradycardia (0.53%), hypotension (0.23%), and acute decompensation (4.97%) were observed, but they were not more frequent than in the placebo-group (0%, 0.3% and 6.74%). The numbers of fatal and disabling strokes during the total study period were 20 in the Bisoprolol group and 15 in the placebo group.</p><p>The CIBIS III trial investigated 1010 patients aged &ge;65 years with mild to moderate chronic heart failure (CHF; NYHA class II or III) and left ventricular ejection fraction &le;35%, who had not been treated previously with ACE inhibitors, beta-blockers, or angiotensin receptor blockers. Patients were treated with a combination of Bisoprolol and enalapril for 6 to 24 months after an initial 6 months treatment with either Bisoprolol or enalapril.</p><p>There was a trend toward higher frequency of chronic heart failure worsening when Bisoprolol was used as the initial 6 months treatment. Non inferiority of Bisoprolol-first versus enalapril-first treatment was not proven in the per-protocol analysis, although the two strategies for initiation of CHF treatment showed a similar rate of the primary combined endpoint death and hospitalization at study end (32.4% in the Bisoprolol-first group vs. 33.1 % in the enalapril-first group, per-protocol population). The study shows that Bisoprolol can also be used in elderly chronic heart failure patients with mild to moderate disease.</p><p>Bisoprolol is also used for the treatment of hypertension and angina.</p><p>In acute administration in patients with coronary heart disease without chronic heart failure Bisoprolol reduces the heart rate and stroke volume and thus the cardiac output and oxygen consumption. In chronic administration the initially elevated peripheral resistance decreases.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption</p><p>Bisoprolol is absorbed and has a biological availability of about 90% after oral administration.</p><p>Distribution</p><p>The distribution volume is 3.5 l/kg. The plasma protein binding of Bisoprolol is about 30%.</p><p>Biotransformation and Elimination</p><p>Bisoprolol is excreted from the body by two routes. 50% is metabolised by the liver to inactive metabolites which are then excreted by the kidneys. The remaining 50% is excreted by the kidneys in an unmetabolised form. Total clearance is approximately 15 l/h. The half-life in plasma of 10-12 hours gives a 24 hour effect after dosing once daily.</p><p>Linearity</p><p>The kinetics of Bisoprolol are linear and independent of age.</p><p>Special population</p><p>Since the elimination takes place in the kidneys and the liver to the same extent a dosage adjustment is not required for patients with impaired liver function or renal insufficiency. The pharmacokinetics in patients with stable chronic heart failure and with impaired liver or renal function has not been studied. In patients with chronic heart failure (NYHA stage III) the plasma levels of Bisoprolol are higher and the half-life is prolonged compared to healthy volunteers. Maximum plasma concentration at steady state is 64+21 ng/ml at a daily dose of 10 mg and the half-life is 17+5 hours.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity or carcinogenicity. Like other beta-blockers, Bisoprolol caused maternal (decreased food intake and decreased body weight) and embryo/fetal toxicity (increased incidence of resorptions, reduced birth weight of the offspring, retarded physical development) at high doses but was not teratogenic.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Microcrystalline Cellulose<br />Dicalcium Phosphate<br />Crospovidone<br />Colloidal Silicon Dioxide<br />Magnesium Stearate<br />HPMC Hypromellose 5 CP<br />Glycerin<br />PEG 6000<br />Talc<br />Titanium Dioxide<br />B-Cor 5 also contains Red Oxide</p><p>B-Cor 10 also contain Sunset Yellow Color</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Don&rsquo;t Store above 30&deg;C.</p><p>Keep out of the reach of children</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Primary packaging material:<br />PVC / PVDC with Aluminium blister pack.<br />Secondary packaging material:</p><p>Printed cardboard case containing the blister packs and the package insert.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jordan Sweden Medical and Sterilization
Joswe-medical
P.O. Box 851831 Amman 11185 Jordan
E-mail: info@joswe.com
www.joswe.com
Tel: +962 6 5859765, +962 6 5728327
Fax: +962 6 5814526, +962 6 5728326
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                June / 2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>